...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: OTC Expert & Grey Market Restrictions

golf... yes it's a complete shot in the dark as to what is available in shares and Bid/Ask.

Glad to see that the stock is still liquid on the OTC.

 

Koo

Share
New Message
Please login to post a reply